Service Overview
Vivipro Biolabs provides a comprehensive portfolio of preclinical services meticulously designed to support the full spectrum of biomedical research needs, from initial model selection through to study execution and completion. The organization’s expertise encompasses the provision of high-quality, well-characterized animal models, a robust suite of specialized in vivo toxicity testing services, and dedicated research support functions. This integrated service model allows Vivipro Biolabs to function as a versatile partner, offering clients streamlined access to essential resources and expertise required for advancing their research programs efficiently and effectively.
Table 1: Vivipro Biolabs Toxicity Study Portfolio
Study Category | Specific Study Offered |
Systemic Toxicity | Acute Toxicity |
Repeated Dose Toxicity (Oral [Gavage/Diet], Dermal, Parenteral) | |
Carcinogenicity | Carcinogenicity Studies |
Developmental & Reproductive Tox. | DART (Segment I, Segment II & Segment III) |
Neurotoxicity | Neurotoxicity Studies |
Local Tolerance | Eye Irritation/Serious Eye Damage (in vivo) |
Skin Irritation/Corrosion (in vivo) | |
Hypersensitivity | Skin Sensitization (Guinea Pig Maximization Test – GPMT) |
Skin Sensitization (Buehler method, in vivo) | |
Immunogenicity | Immunogenicity Studies |
This diverse range of validated toxicological assays underscores Vivipro Biolabs’ capability to support various stages of drug development and chemical safety assessment.


